View New Articles By
The Damon Runyon Cancer Research Foundation has named the newest cohort of the Damon Runyon Scholars Program for Advancing Research and Knowledge (SPARK), a one-year cancer research internship for post-baccalaureate scholars. Launched in 2023, the program provides promising young talent with rigorous scientific training and a network of mentors and peers to support their next steps into graduate school and beyond.
The Damon Runyon Cancer Research Foundation has named 16 new Damon Runyon Fellows, brilliant postdoctoral scientists conducting basic and translational cancer research in the laboratories of leading senior investigators. This prestigious Fellowship encourages the nation's most promising young scientists to pursue careers in cancer research by providing them with independent funding ($300,000 total over four years) to investigate cancer causes, mechanisms, therapies, and prevention.
The Damon Runyon Cancer Research Foundation has named five new Damon Runyon Clinical Investigators. The recipients of this prestigious award are outstanding, early-career physician-scientists conducting patient-oriented cancer research at major research centers under the mentorship of the nation's leading scientists and clinicians.
Three exceptional young clinicians with novel approaches to fighting cancer have been named the 2025 recipients of the Damon Runyon Physician-Scientist Training Award. This award, established to help bolster the ranks of this vital cohort of cancer researchers, provides physicians who have completed clinical specialty fellowship training with the opportunity to become leaders in translational and clinical research. The awardees are selected through a highly competitive and rigorous process by a committee of leading cancer researchers who are themselves physician-scientists.
The Damon Runyon Cancer Research Foundation today announced the launch of the Innovative Ventures in Early-Stage Technologies (InVEST) Program. This unique initiative will automatically provide the first seed check to biotech startups founded by Damon Runyon alumni scientists. The goal of the program is to catalyze billions of dollars in commercial funding for scientific discovery while generating long-term, sustainable support for future cancer research breakthroughs.
Damon Runyon has announced a new cohort of Quantitative Biology Fellows, five exceptional early-career scientists who are bringing cutting-edge computational tools to bear on some of the most important questions in cancer biology. Whether designing new proteins or mapping DNA structure, their projects aim to shed light on these fundamental questions through large-scale data collection, mathematical modeling, and quantitative analysis.
The Damon Runyon Cancer Research Foundation has named 13 new Damon Runyon Fellows, exceptional postdoctoral scientists conducting basic and translational cancer research in the laboratories of leading senior investigators. The prestigious, four-year Fellowship encourages the nation's most promising young scientists to pursue careers in cancer research by providing them with independent funding ($300,000 total) to investigate cancer causes, mechanisms, therapies, and prevention.
The Damon Runyon Cancer Research Foundation and St. Jude Children’s Research Hospital have announced their newest class of pediatric cancer research fellows, each of whom will receive funding for four years ($300,000 total) to support an innovative research project with the potential to significantly impact the diagnosis or treatment of one or more pediatric cancers.
CONNECT
1.877.7CANCER
info@damonrunyon.org
One Exchange Plaza
55 Broadway, Suite 302
New York, NY 10006
